{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:58:51Z","timestamp":1793228331763,"version":"4.5.0"},"reference-count":106,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2021\/41\/N\/NZ6\/02682, 2022\/45\/B\/NZ5\/04226, 2020\/39\/B\/NZ5\/02893, 2021\/41\/B\/NZ6\/02436"],"award-info":[{"award-number":["2021\/41\/N\/NZ6\/02682, 2022\/45\/B\/NZ5\/04226, 2020\/39\/B\/NZ5\/02893, 2021\/41\/B\/NZ6\/02436"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023181","name":"Agencja Bada\u0144 Medycznych","doi-asserted-by":"publisher","award":["2024\/ABM\/08\/00106\/P\/02"],"award-info":[{"award-number":["2024\/ABM\/08\/00106\/P\/02"]}],"id":[{"id":"10.13039\/501100023181","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Cancer immunotherapy has transformed oncology, yet durable benefits remain limited to a subset of patients, and those cases are incompletely explained by tumor-intrinsic biomarkers alone. Growing evidence indicates that the host immune state is a critical contextual determinant of therapeutic response and may itself be shaped by psychological distress. In cancer patients, such distress-related states have been associated with altered neuroendocrine activity and related cortisol regulation, inflammation, reduced natural killer cell function, and broader immune dysregulation. In parallel, preclinical studies show that glucocorticoid and adrenergic signaling can impair antitumor immunity by promoting T-cell dysfunction, metabolic exhaustion, and increased inhibitory signaling, as well as suppressing antigen presentation. Emerging clinical studies in patients receiving immune checkpoint inhibitors further suggest that emotional distress before immunotherapy initiation is associated with poorer progression-free survival, response, and overall survival outcomes in several cancer settings, including non-small-cell lung cancer, gastroesophageal cancer, gastric cancer, and recurrent high-grade glioma. As these patient data remain largely observational, current evidence supports psychological distress as a putative host-state modifier or correlate, rather than as a proven causal determinant, of immunotherapy response. These observations support a psycho-neuro-immune framework in which psychological distress may identify or contribute to a host state that is less permissive for effective immunotherapy. Here, we review evidence linking host immune competence to immunotherapy efficacy, summarize clinical and molecular data connecting distress to immune dysregulation in cancer, and incorporate emerging evidence that brain\u2013body signaling may shape tumor immunity through neural, endocrine, and immune pathways. We propose that psychological distress should be considered not merely as a parallel quality-of-life variable, but as a biologically relevant and clinically verifiable host-state factor with implications for biomarker development and future host-modulation immunotherapy trials.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1891642","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:51:28Z","timestamp":1785408688000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Psychological distress as a putative host-state determinant of cancer immunotherapy response"],"prefix":"10.3389","volume":"17","author":[{"given":"Agnieszka","family":"Bronisz","sequence":"first","affiliation":[{"name":"Tumor Microenvironment Laboratory, Mossakowski Medical Research Institute, Polish Academy of Sciences","place":["Warsaw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaudia","family":"Kiel","sequence":"additional","affiliation":[{"name":"Tumor Microenvironment Laboratory, Mossakowski Medical Research Institute, Polish Academy of Sciences","place":["Warsaw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Godlewski","sequence":"additional","affiliation":[{"name":"Department of NeuroOncology, Mossakowski Medical Research Institute, Polish Academy of Sciences","place":["Warsaw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00347-z","article-title":"Systemic immunity in cancer","volume":"21","author":"Hiam-Galvez","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101621","article-title":"Advances and prospects of biomarkers for immune checkpoint inhibitors","volume":"5","author":"Yamaguchi","year":"2024","journal-title":"Cell Rep Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2406063","article-title":"Predictive biomarkers for immune checkpoint inhibitors therapy in lung cancer","volume":"20","author":"Yao","year":"2024","journal-title":"Hum Vaccin Immunother"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17162639","article-title":"Immune biomarkers for checkpoint blockade in solid tumors: transitioning from tissue to peripheral blood monitoring and future integrated strategies","volume":"17","author":"Trontzas","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1705327114","article-title":"Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients","volume":"114","author":"Kamphorst","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16142592","article-title":"Baseline blood CD8(+) T cell activation potency discriminates responders from non-responders to immune checkpoint inhibition combined with stereotactic radiotherapy in non-small-cell lung cancer","volume":"16","author":"Kievit","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1325330","article-title":"Peripheral blood lymphocyte subsets predict the efficacy of TACE with or without PD-1 inhibitors in patients with hepatocellular carcinoma: a prospective clinical study","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-24-405","article-title":"The peripheral CD4(+) T cells predict efficacy in non-small cell lung cancer (NSCLC) patients with the anti-PD-1 treatment","volume":"13","author":"Zhuang","year":"2024","journal-title":"Transl Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.04.008","article-title":"Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in patients with cancer","volume":"42","author":"Dyikanov","year":"2024","journal-title":"Cancer Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s00262-025-03966-9","article-title":"Monitoring peripheral blood data supports the prediction of immunotherapy response in advanced non-small cell lung cancer based on real-world data","volume":"74","author":"Ramos-Guerra","year":"2025","journal-title":"Cancer Immunol Immunother"},{"key":"B11","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41598-024-84890-3","article-title":"Pretreatment neutrophil-to-lymphocyte ratio is associated with immunotherapy efficacy in patients with advanced cancer: a systematic review and meta-analysis","volume":"15","author":"Su","year":"2025","journal-title":"Sci Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1080\/1750743X.2024.2379230","article-title":"Peripheral blood cytokines and outcomes with immune checkpoint blockade: a systematic review and meta-analysis","volume":"16","author":"Karol","year":"2024","journal-title":"Immunotherapy"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70654","article-title":"Clinical application of peripheral blood biomarkers for solid tumors","volume":"7","author":"Tu","year":"2026","journal-title":"MedComm"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.10.015","article-title":"Social support, psychological distress, and natural killer cell activity in ovarian cancer","volume":"23","author":"Lutgendorf","year":"2005","journal-title":"J Clin Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-809324-5.02208-2","article-title":"Stress: concepts, definition and history","author":"G.","year":"2016","journal-title":"Neurosci Biobehav Psychol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.3259","article-title":"Emotional distress: the sixth vital sign in cancer care","volume":"23","author":"Bultz","year":"2005","journal-title":"J Clin Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2013.0027","article-title":"Distress management","volume":"11","author":"Holland","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fnint.2011.00055","article-title":"Unpredictability and uncertainty in anxiety: a new direction for emotional timing research","volume":"5","author":"Lake","year":"2011","journal-title":"Front Integr Neurosci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2006.09.011","article-title":"Psychologic stress, reduced NK cell activity, and cytokine dysregulation in women experiencing diagnostic breast biopsy","volume":"32","author":"Witek-Janusek","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2008.01.012","article-title":"Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer","volume":"22","author":"Witek-Janusek","year":"2008","journal-title":"Brain Behav Immun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1177\/1534735410370036","article-title":"Association of IL-6, hypothalamus-pituitary-adrenal axis function, and depression in patients with cancer","volume":"9","author":"Jehn","year":"2010","journal-title":"Integr Cancer Ther"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2007.05.001","article-title":"Interleukin-6 levels and HPA axis activation in breast cancer patients with major depressive disorder","volume":"31","author":"Soygur","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042324","article-title":"Depressive symptoms and cortisol rhythmicity predict survival in patients with renal cell carcinoma: role of inflammatory signaling","volume":"7","author":"Cohen","year":"2012","journal-title":"PLoS One"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31943","article-title":"The impact of psychosocial stress and stress management on immune responses in patients with cancer","volume":"125","author":"Antoni","year":"2019","journal-title":"Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017228","article-title":"Psychological intervention and its immune effect in cancer patients: a meta-analysis","volume":"98","author":"Zhang","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34193","article-title":"Cancer-related inflammation and depressive symptoms: systematic review and meta-analysis","volume":"128","author":"McFarland","year":"2022","journal-title":"Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12905-025-03674-7","article-title":"Expression of inflammatory states in response to psychological distress in breast cancer survivors and its relationship to subjective memory function complaints","volume":"25","author":"Gan","year":"2025","journal-title":"BMC Womens Health"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2026.218318","article-title":"Bidirectional relationship between cancer and depression: from shared mechanisms to integrated therapeutic strategies","volume":"643","author":"Liu","year":"2026","journal-title":"Cancer Lett"},{"key":"B29","doi-asserted-by":"publisher","first-page":"7041","DOI":"10.1038\/s41467-021-27349-7","article-title":"Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance","volume":"12","author":"Deng","year":"2021","journal-title":"Nat Commun"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-018-2243-8","article-title":"Beta-adrenergic signaling blocks murine CD8(+) T-cell metabolic reprogramming during activation: a mechanism for immunosuppression by adrenergic stress","volume":"68","author":"Qiao","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-20-0445","article-title":"Chronic adrenergic stress contributes to metabolic dysfunction and an exhausted phenotype in T cells in the tumor microenvironment","volume":"9","author":"Qiao","year":"2021","journal-title":"Cancer Immunol Res"},{"key":"B32","article-title":"Chronic stress promotes tumor immune evasion via the suppression of MHC-I expression and the upregulation of PD-L1","volume":"12","author":"Chen","year":"2022","journal-title":"Am J Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.08.005","article-title":"Endogenous glucocorticoid signaling regulates CD8(+) T cell differentiation and development of dysfunction in the tumor microenvironment","volume":"53","author":"Acharya","year":"2020","journal-title":"Immunity"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-025-01358-9","article-title":"Pretreatment emotional distress and peripheral biomarkers predict immune checkpoint inhibitor response in people with advanced inoperable gastroesophageal cancer","volume":"6","author":"Huang","year":"2026","journal-title":"Commun Med (Lond)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1516643","article-title":"Association between emotional distress and the efficacy of advanced gastric cancer patients undergoing treatment with immune checkpoint inhibitors: a cohort study and propensity score matching study","volume":"15","author":"Tian","year":"2025","journal-title":"Front Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdag040","article-title":"Emotional distress impairs immune checkpoint blockade efficacy in recurrent high-grade glioma: insights from tumor in situ fluid analysis","volume":"8","author":"Wang","year":"2026","journal-title":"Neurooncol Adv"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/cells12202471","article-title":"Linkage between psychological factors and response to immune checkpoint inhibitor therapy: a preliminary study","volume":"12","author":"Cohen","year":"2023","journal-title":"Cells"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1177\/17588359251371826","article-title":"Association between pretreatment emotional distress and survival outcomes in patients with advanced non-small-cell lung cancer: an individual patient data meta-analysis of 4632 patients in seven trials","volume":"17","author":"Li","year":"2025","journal-title":"Ther Adv Med Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02929-4","article-title":"Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer","volume":"30","author":"Zeng","year":"2024","journal-title":"Nat Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02631-x","article-title":"Association between pretreatment emotional distress and neoadjuvant immune checkpoint blockade response in melanoma","volume":"29","author":"Fraterman","year":"2023","journal-title":"Nat Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.79.0006","article-title":"Impact of baseline steroids on efficacy of programmed cell death-1 and programmed death-ligand 1 blockade in patients with non-small-cell lung cancer","volume":"36","author":"Arbour","year":"2018","journal-title":"J Clin Oncol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00189","article-title":"Immune checkpoint inhibitor outcomes for patients with non-small-cell lung cancer receiving baseline corticosteroids for palliative versus nonpalliative indications","volume":"37","author":"Ricciuti","year":"2019","journal-title":"J Clin Oncol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41392-025-02241-8","article-title":"Neuro-immune crosstalk in cancer: mechanisms and therapeutic implications","volume":"10","author":"Pu","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-0546","article-title":"Beta-adrenergic signaling in mice housed at standard temperatures suppresses an effector phenotype in CD8(+) T cells and undermines checkpoint inhibitor therapy","volume":"77","author":"Bucsek","year":"2017","journal-title":"Cancer Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0566-4","article-title":"Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity","volume":"25","author":"Yang","year":"2019","journal-title":"Nat Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-2291","article-title":"Concurrent dexamethasone limits the clinical benefit of immune checkpoint blockade in glioblastoma","volume":"27","author":"Iorgulescu","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003368","article-title":"Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models","volume":"10","author":"Koch","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02347-y","article-title":"Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1\/2 trial","volume":"29","author":"Nassiri","year":"2023","journal-title":"Nat Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06623-2","article-title":"Clinical trial links oncolytic immunoactivation to survival in glioblastoma","volume":"623","author":"Ling","year":"2023","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2012.01.013","article-title":"Chronic stress enhances progression of acute lymphoblastic leukemia via beta-adrenergic signaling","volume":"26","author":"Lamkin","year":"2012","journal-title":"Brain Behav Immun"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1126\/science.1236361","article-title":"Autonomic nerve development contributes to prostate cancer progression","volume":"341","author":"Magnon","year":"2013","journal-title":"Science"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.11.007","article-title":"Beta2 adrenergic-neurotrophin feedforward loop promotes pancreatic cancer","volume":"33","author":"Renz","year":"2018","journal-title":"Cancer Cell"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2025.05.031","article-title":"Cholinergic neuronal activity promotes diffuse midline glioma growth through muscarinic signaling","volume":"188","author":"Drexler","year":"2025","journal-title":"Cell"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06036-1","article-title":"Glioblastoma remodelling of human neural circuits decreases survival","volume":"617","author":"Krishna","year":"2023","journal-title":"Nature"},{"key":"B55","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.1038\/s41467-025-60074-z","article-title":"Glioma-neuronal circuit remodeling induces regional immunosuppression","volume":"16","author":"Nejo","year":"2025","journal-title":"Nat Commun"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06678-1","article-title":"Glioma synapses recruit mechanisms of adaptive plasticity","volume":"623","author":"Taylor","year":"2023","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1564-x","article-title":"Glutamatergic synaptic input to glioma cells drives brain tumour progression","volume":"573","author":"Venkataramani","year":"2019","journal-title":"Nature"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2025.09.029","article-title":"Cancer cells co-opt an inter-organ neuroimmune circuit to escape immune surveillance","volume":"188","author":"Zhang","year":"2025","journal-title":"Cell"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1576-6","article-title":"Synaptic proximity enables NMDAR signalling to promote brain metastasis","volume":"573","author":"Zeng","year":"2019","journal-title":"Nature"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00519-w","article-title":"Reciprocal interactions between innate immune cells and astrocytes facilitate neuroinflammation and brain metastasis via lipocalin-2","volume":"4","author":"Adler","year":"2023","journal-title":"Nat Cancer"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3513","article-title":"REDD1 is essential for stress-induced synaptic loss and depressive behavior","volume":"20","author":"Ota","year":"2014","journal-title":"Nat Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-021-01065-6","article-title":"Type 1 interferon mediates chronic stress-induced neuroinflammation and behavioral deficits via complement component 3-dependent pathway","volume":"26","author":"Tripathi","year":"2021","journal-title":"Mol Psychiatry"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4245","article-title":"Resilience to chronic stress is mediated by noradrenergic regulation of dopamine neurons","volume":"19","author":"Isingrini","year":"2016","journal-title":"Nat Neurosci"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2026.05.018","article-title":"Macrophage-mediated brain-bone marrow crosstalk promotes chronic stress-induced glioma growth","author":"Yang","year":"2026","journal-title":"Cancer Cell"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-23-0378","article-title":"Chronic stress exacerbates the immunosuppressive microenvironment and progression of gliomas by reducing secretion of CCL3","volume":"12","author":"Wang","year":"2024","journal-title":"Cancer Immunol Res"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4133","article-title":"Activation of the reward system boosts innate and adaptive immunity","volume":"22","author":"Ben-Shaanan","year":"2016","journal-title":"Nat Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1038\/s41467-018-05283-5","article-title":"Modulation of anti-tumor immunity by the brain's reward system","volume":"9","author":"Ben-Shaanan","year":"2018","journal-title":"Nat Commun"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31714-7","article-title":"Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study","volume":"389","author":"Tawakol","year":"2017","journal-title":"Lancet"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0279235","article-title":"Amygdalar activity measured using FDG-PET\/CT at head and neck cancer staging independently predicts survival","volume":"18","author":"Hassan","year":"2023","journal-title":"PLoS One"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3978","article-title":"Sympathetic nervous system regulation of the tumour microenvironment","volume":"15","author":"Cole","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00395-5","article-title":"Stress and cancer: mechanisms, significance and future directions","volume":"21","author":"Eckerling","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.3651","article-title":"Biomarker: predictive or prognostic?","volume":"33","author":"Ballman","year":"2015","journal-title":"J Clin Oncol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71326","article-title":"Associations between anxiety or depression diagnosis and immune checkpoint inhibitor outcomes","volume":"14","author":"Derry-Vick","year":"2025","journal-title":"Cancer Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"6664","DOI":"10.1038\/s41467-021-26992-4","article-title":"Psychological stress impairs IL22-driven protective gut mucosal immunity against colonising pathobionts","volume":"12","author":"Shaler","year":"2021","journal-title":"Nat Commun"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1649486","article-title":"Associations between chemoradiotherapy-based immune checkpoint blockade and posttreatment depression and anxiety in head and neck cancer patients: a cross-sectional study","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j108","article-title":"Psychological distress in relation to site specific cancer mortality: pooling of unpublished data from 16 prospective cohort studies","volume":"356","author":"Batty","year":"2017","journal-title":"BMJ"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1186\/s12885-025-15161-1","article-title":"The impact of anxiety and depression on hematologic malignancy outcomes: a systematic review and meta-analysis","volume":"25","author":"Salabat","year":"2025","journal-title":"BMC Cancer"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.34.8466","article-title":"Frequency, clinical associations, and longitudinal course of major depressive disorder in adults with cerebral glioma","volume":"29","author":"Rooney","year":"2011","journal-title":"J Clin Oncol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11164811","article-title":"Depression and quality of life in patients with gliomas: a narrative review","volume":"11","author":"Hu","year":"2022","journal-title":"J Clin Med"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1227\/01.NEU.0000159648.44507.7F","article-title":"Depression in relation to survival among neurosurgical patients with a primary brain tumor: a 5-year follow-up study","volume":"56","author":"Mainio","year":"2005","journal-title":"Neurosurgery"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2018.06.016","article-title":"Depression and survival of glioma patients: a systematic review and meta-analysis","volume":"172","author":"Shi","year":"2018","journal-title":"Clin Neurol Neurosurg"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27020686","article-title":"The impact of chronic stress on treatment outcomes of cancer patients with divergent survival rates: a systematic review","volume":"27","author":"Herbetko","year":"2026","journal-title":"Int J Mol Sci"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2502760","article-title":"Structured exercise after adjuvant chemotherapy for colon cancer","volume":"393","author":"Courneya","year":"2025","journal-title":"N Engl J Med"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-25-0682","article-title":"A retrospective cohort study of physical activity and survival in patients treated with immune checkpoint inhibitors","volume":"34","author":"Parker","year":"2025","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1694045","article-title":"Association between exercise and clinical outcomes in patients treated with immunotherapy for solid tumors","volume":"16","author":"Loo","year":"2025","journal-title":"Front Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2024.107702","article-title":"A randomized trial of aerobic exercise in colorectal cancer: rationale, design, recruitment, and exercise adherence results","volume":"146","author":"Compton","year":"2024","journal-title":"Contemp Clin Trials"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-025-01184-y","article-title":"The efficacy and safety of beta-blockers and immune checkpoint inhibitors in patients with cancer: a systematic review and meta-analysis","volume":"20","author":"Tokunaga","year":"2025","journal-title":"Target Oncol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1693249","article-title":"The impact of beta-blockers on outcomes of immune checkpoint inhibitors therapy in advanced lung cancer: a multicenter real-world study","volume":"16","author":"Chang","year":"2025","journal-title":"Front Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.77.1097","article-title":"Managing cancer and living meaningfully (CALM): a randomized controlled trial of a psychological intervention for patients with advanced cancer","volume":"36","author":"Rodin","year":"2018","journal-title":"J Clin Oncol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1002\/pon.70021","article-title":"Effect of behavioral activation on stigma and quality of life in patients with advanced esophageal and gastric cancer: a randomized controlled trial","volume":"33","author":"Huang","year":"2024","journal-title":"Psychooncology"},{"key":"B94","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41398-025-03507-z","article-title":"Treatments of depressive symptoms in cancer patients: a systematic review and network meta-analysis","volume":"15","author":"Fu","year":"2025","journal-title":"Transl Psychiatry"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2025.106396","article-title":"The effect of mindfulness-based meditation on the immune function of breast cancer patients: a systematic review and three-level meta-analysis","volume":"179","author":"Yu","year":"2025","journal-title":"Neurosci Biobehav Rev"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109957","article-title":"Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug","volume":"37","author":"Bi","year":"2021","journal-title":"Cell Rep"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3390\/ph16050640","article-title":"Association between fluoxetine use and overall survival among patients with cancer treated with PD-1\/L1 immunotherapy","volume":"16","author":"Magagnoli","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J Psychopharmacol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J Psychopharmacol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2017.02.006","article-title":"Sex differences in the neuro-immune consequences of stress: focus on depression and anxiety","volume":"67","author":"Bekhbat","year":"2018","journal-title":"Brain Behav Immun"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.120.266205","article-title":"Sex differences in the inflammatory consequences of stress: implications for pharmacotherapy","volume":"375","author":"Martinez-Muniz","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2010.09.005","article-title":"Neuroendocrine effects of stress on immunity in the elderly: implications for inflammatory disease","volume":"31","author":"Heffner","year":"2011","journal-title":"Immunol Allergy Clin North Am"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-014-9631-6","article-title":"Stress, ageing and their influence on functional, cellular and molecular aspects of the immune system","volume":"36","author":"Vitlic","year":"2014","journal-title":"Age (Dordr)"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1097\/NNR.0000000000000636","article-title":"Social determinants of health and symptom burden during cancer treatment","volume":"72","author":"Badger","year":"2023","journal-title":"Nurs Res"},{"key":"B105","article-title":"Social determinants of health and cancer survivorship","volume":"7","author":"Coughlin","year":"2021","journal-title":"J Environ Health Sci"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1664443","article-title":"Optimizing early-phase immunotherapy trials: the role of biomarker enrichment strategies","volume":"16","author":"Catani","year":"2025","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1891642\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:51:29Z","timestamp":1785408689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1891642\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":106,"alternative-id":["10.3389\/fimmu.2026.1891642"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1891642","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"article-number":"1891642"}}